CBD LIFE SCIENCES INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0031 USD | 0.00% |
|
-22.50% | +933.33% |
| 2023 | CBD Life Sciences Inc. Launches Premium Terpene Infused Oil | CI |
| 2022 | CBD Life Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 | CI |
Sales per Business
| USD in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
Organic Cannabidiol Based Supplements and Wellness Products
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +4.31% |
Sales per region
| USD in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +4.31% |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
Lisa Nelson
CEO | Chief Executive Officer | 50 | 16-12-31 |
Brianna Nelson
BRD | Director/Board Member | 25 | - |
Matthew McGee
SAM | Sales & Marketing | 25 | 21-06-02 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
Lisa Nelson
CEO | Chief Executive Officer | 50 | 16-12-31 |
Brianna Nelson
BRD | Director/Board Member | 25 | - |
Company contact information
CBD Life Sciences, Inc.
10953 North Frank Lloyd Wright Boulevard
85259, Scottsdale
+
Sector
This company's sector is not yet available
- Stock Market
- Equities
- CBDL Stock
- Company CBD Life Sciences Inc.
